Lassa fever in West African sub-region: An overview

Journal of Vector Borne Diseases

Volumn 44, Issue 1, 2007, Pages 1-11

  Ogbu, O ^a   Ajuluchukwu, E ^a   Uneke, C J ^a  

^a EBONYI STATE UNIVERSITY   (Nigeria)

Author keywords

Infection; Lassa fever; Mastomys natalensis; West Africa

Indexed keywords

ANTIBIOTIC AGENT; PARACETAMOL; QUININE; RIBAVIRIN; RINGER LACTATE SOLUTION; VIRUS VACCINE;

AFRICA; ARENAVIRUS; BLOOD TRANSFUSION; CLINICAL FEATURE; DISEASE CARRIER; DISEASE TRANSMISSION; FLUID THERAPY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HEMORRHAGIC FEVER; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LASSA FEVER; LASSA VIRUS; MASTOMYS; NONHUMAN; REVIEW; RODENT; TERATOGENICITY; TROPICAL DISEASE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN; ZOONOSIS;

AFRICA, WESTERN; ANIMALS; DISEASE RESERVOIRS; HUMANS; LASSA FEVER; LASSA VIRUS; MURINAE;

EID: 33847698212     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Imported Lassa fever. New Jersey: Centers for Disease Control and Prevention (CDC) 2004. MMWR Morb Mortal Wkly Rep 2004; 53(38): 894-7.
2. Keenlyside RA, McCormick JB, Webb PA, Smith E, Elliott L, Johnson KM. Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. Am J Trop Med Hyg 1983; 32: 829-37.
3. Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 1974; 185: 263-5.
4. Carey DE, Kemp GE, White HA, Pinneo L, Addy RF, Fom AL, et al. Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg 1972; 66: 402-8.
5. Frame JD, Baldwin JM, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 1970; 19: 670-6.
6. Monath TP, Maher M, Casals J, Kissling RE, Cacciapuoti A. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg 1974; 23: 1140-9.
7. Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, Pinneo L, et al. A hospital epidemic of lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg 1973; 22: 773-9.
8. Lassa fever. WHO Newsletter, Geneva 2005.
9. Gunther S, Lenz O. Lassa virus. Crit Rev Clin Lab Sci 2004; 41(4): 339-90.
10. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagnor L, McCormick JB. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br Med J 1995; 311: 857-9.
11. Mertens PE, Patton R, Baum JJ, Monath TP. Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg 1973; 22: 780-4.
12. White HA. Lassa fever: a study of 23 hospital cases. Trans R Soc Trop Med Hyg 1972; 66: 390-8.
13. Buckley SM, Casals J. Lassa fever, a new virus disease of man from West Africa. III. Isolation and characterization of the virus. Am J Trop Med Hyg 1970; 19: 680-91.
14. Bowen GS, Tomori O, Wulff H, Casals J, Noonan A, Downs WG. Lassa fever in Onitsha, East Central State, Nigeria in 1974. Bull WHO 1975; 52: 599-604.
15. Monath TP. Lassa fever: a review of the epidemiology and epizootiology. Bull WHO 1975; 52: 577-92.
16. Dr. Tim Menakayi public health leaflets on what your need to know about Lassa fever. Abuja, Nigeria: Federal Ministry of Health 2000.
17. Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, et al. Lassa fever in the United States. Investigation of a case and new guidelines for management. New Engl J Med 1990; 323: 1120-3.
18. Mahdy MS, Chiang W, McLaughlin B, Derksen K, Truxton BH, Neg K. Lassa fever: the first confirmed case imported into Canada. Can Dis Wkly Rep 1989;15: 193-8.
19. Zweighaft RM, Fraser DW, Hattwick MA, Winkler WG, Jordan WC, Alter M, et al. Lassa fever: response to an imported case. New Engl J Med 1977; 297: 803-7.
20. Johnson KM, Monath TP. Imported Lassa fever: reexamining the algorithms. New Engl J Med 1990; 323: 1139-41.
21. Bowen MD, Peters CJ, Nichol ST. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol 1997; 8: 301-16.
22. Jahrling PB, Frame JD, Smith SB, Monson MH. Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg 1985; 79: 374-9.
23. Ruo SL, Mitchell SW, Kiley MP, Roumillat LF, Fisher-Hoch SP, McCormick JB. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Genet Virol 1991; 72: 549-55.
24. Auperin DD, McCormick JB. Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology 1989; 168: 421-5.
25. Auperin DD, Sasso DR, McCormick JB. Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology 1986; 154: 155-67.
26. McCormick JB. Arenaviruses. In: Fields BN, Knipe DM editors. Fields virology. New York : Raven Press 1990; p.1245-67.
27. McCormick JB. Epidemiology and control of Lassa fever. Curr Top Microbiol Immunol 1987; 134: 69-78.
28. Gunther S, Emmerich P, Laue T, Kuhle O, Asper M, Jung A, Grewing T, terMeulen J, Schmitz H. Imported Lassa fever in Germany: molecular characterization of a new Lassa virus strain. Emerg Infect Dis 2000; 6(5): 466-76.
29. Lozano ME, Posik DM, Albarino CG, Schujman G, Ghiringhelli PD, Calderon G, Sabattini M, Romanowski V. Characterisation of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis. Its potential use for detection of uncharacterised arena viruses. Virus Res 1997; 49: 79-89.
30. Clegg JC, Wilson SM, Oram JD. Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arena virus gene products. Virus Res 1991; 18: 151-64.
31. terMeulen J, Koulemou K, Wittekindt T, Windisch K, Strigl S, Conde S, et al. Detection of lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol 1998; 36: 3143-8.
32. Demby AH, Chamberlain J, Brown DW, Clegg CS. Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol 1994; 32: 2898-903.
33. Southern PJ. Arenaviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM editors. Fields virology. Philadelphia :Lippencott-Raven, PaRaven 1996; p. 1505-19.
34. Burns JW, Buchmeier MJ. Glycoproteins of the arenaviruses. In: Salvato MS editor. The Arenaviridae. New York : Plenum Press 1993; p. 17-35.
35. Auperin DD, Galinski M, Bishop DH. The sequences of the N protein gene and intergenic region of the S RNA of Pichinde arenavirus. Virology 1984; 134: 208-19.
36. Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, Bajani MD, Peters CJ, Nichol ST.Genetic diversity among Lassa virus strains. J Virol 2000; 74(15): 6992-7004.
37. Granjon L, DuPlantier JM, Catalan J, Britton-Davidian J. Systematics of the genus Mastomys (Thomas 1915) (Rodentia: Muridae). Belg J Zool 1997; 127: 7-18.
38. Bloch A. A serological survey of Lassa fever in Liberia. Bull WHO 1978; 56: 811-3.
39. McCorrnick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 1987; 155: 437-44.
40. Bausch DG, Demby AH, Coulibaly M, Kanu J, Goba A, Bah A, Conde N, Wurtzel HL, Cavallaro KF, Lloyd E, Baldet FB, Cisse SD, Fofona D, Savane IK, Tolno RT, Mahy B, Wagoner KD, Ksiazek TG Peters CJ, Rollin PE. Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vect Borne Zoon Dis 2001; 1(4): 269-81.
41. Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Br Med J 1988; 297: 584-7.
42. Harper TK. Lassa Fever. TKH virology notes 2004. http://www.tarakharper.com/v_lassa.htm.
43. Gunther S, Weisner B, Roth A, Grewing T, Asper M, Drosten C, Emmerich P, Petersen J, Wilczek M, Schmitz H. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis 2001; 184(3): 345-9.
44. Fleischer K, Kohler B, Kirchner A, Schmid J. Lassa fever (Article in German). Med Klin (Munich) 2000; 95(6): 340-5.
45. Fisher-Hoch S, McCormick JB, Sasso D, Craven RB. Hematologic dysfunction in Lassa fever. J Med Virol 1988; 26(2): 127-35.
46. Cummins D. Lassa fever. Br J Hosp Med 1990; 43(3): 186-8, 190 & 192.
47. Liao BS, Byl FM, Adour KK. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause. Otolaryngol Head Neck Surg 1992; 106(3): 226-9.
48. Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, Fisher-Hoch SP. Acute sensorineural deafness in Lassa fever. J Am Med Assoc 1990; 264(16): 2093-6.
49. Update on Lassa fever in West Africa. WHO Wkly Epidemiol Rec 2005; 10(11): 86-7.
50. McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, Smith ES, Trippel S, Tong TC. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 1987; 155: 445-55.
51. Wulff H, Lange JV. Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bull WHO 1975; 52: 429-36.
52. VanderWaals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Trop Geogr Med 1986; 38: 209-14.
53. Ivanov AP, Tkachenko EA, Vander Groen G, Butneko AM, Konstantinov OK. Indirect enzyme-immunoassay for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers. Vopr Virusol 1986; 2: 186-90.
54. Jahrling PB, Niklasson BS, McCormick JB. Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody. Lancet 1985; i: 250-2.
55. Niklasson BS, Jahrling PB, Peters CJ. Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay. J Clin Microbiol 1984; 20: 239-44.
56. Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ, Ksiazek TG Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 2000; 38(7): 2670-7.
57. Lunkenheimer K, Hufert FT, Schmitz H. Detection of Lassa virus RNA specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol 1990; 28: 2689-92.
58. Trappier SG, Conaty AL, Farrar BB, Auperin DD, McCormick JB, Fisher-Hoch SP. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg 1993; 49: 214-21.
59. Jahrling PB, Hesse RA, Eddy GA, Johnson KM, Callis RT, Stephen EL. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis 1980; 141: 580-9.
60. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. Lassa fever: effective therapy with Ribavirin. New Eng J Med 1986; 314: 20-6.
61. Fisher-Hoch SP, Gborie S, Parker L, Huggins J. Unexpected adverse reactions during a clinical trial in rural West Africa. Antivir Res 1992; 19: 139-47.
62. Kochhar DM. Effects of exposure to high concentrations of ribavirin in developing embryos. Pediatr Infect Dis 1990; 9: S88-S90.
63. Fisher-Hoch SP, Hutwagner L, Brown B, McCormick JB. Effective vaccine for lassa fever. J Virol 2000; 74(15): 6777-83.
64. Fisher-Hoch SP, McCormick JB, Auperin DD, Brown BG, Castor M, Perez G, Ruo S, Conaty A, Brammer L, Bauer S. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci USA 1989; 86: 317-21.
65. Fisher-Hoch SP, McCormick JB. Lassa fever vaccine. Expert Rev Vaccines 2004; 3(2): 189-97.